After the IL-23 inhibitor's approval in 2023 to treat ulcerative colitis, the agency has now signed off on Omvoh to treat Crohn's disease. Specifically, the FDA approved Omvoh to treat moderately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback